Recombinant Human PTP4A2 Protein，His

PTP4A2, also known as protein tyrosine phosphatase 4A2, is a member of the protein tyrosine phosphatase family, which plays a critical role in various cellular processes, including signal transduction, cell growth, and differentiation. Its dysregulation has been implicated in several diseases, particularly cancer, making it a significant target for therapeutic intervention. The interest in PTP4A2 has grown due to its association with increased cell motility and metastasis, highlighting its potential role in promoting aggressive tumor phenotypes. Research efforts have focused on the structural and functional characterization of PTP4A2, aiming to elucidate its enzymatic mechanisms and regulatory pathways. Additionally, the development of recombinant PTP4A2 proteins has enabled scientists to explore its biological functions in vitro and in vivo. These studies could ultimately lead to the identification of small-molecule inhibitors that selectively target PTP4A2, offering promising avenues for cancer treatment and other related disorders. Furthermore, the investigation of PTP4A2's interactions with various substrates and signaling molecules is critical for understanding its role in cellular physiology and pathology, providing insights that may enhance therapeutic strategies against malignancies where PTP4A2 is overexpressed or misregulated. Overall, the ongoing research on PTP4A2 not only sheds light on its biological significance but also holds potential for advancing cancer therapeutics.